54 results
8-K
EX-99.1
GLYC
GlycoMimetics Inc
10 Jul 14
Glycomimetics Appoints Mark A. Goldberg, M.D. to Board of Directors
12:00am
, M.D. to its Board of Directors. Dr. Goldberg is Executive Vice President, Medical and Regulatory Strategy at Synageva BioPharma Corporation … statements about its strategy, its future operations, clinical development of its therapeutic candidates, timing of the availability of data from
8-K
EX-99.2
GLYC
GlycoMimetics Inc
4 Apr 14
GlycoMimetics Reports Fourth Quarter and Year-End 2013 Results
12:00am
compliance, capital strategy and planning, until SXC Health Solutions (now Catamaran Corporation) acquired Catalyst in 2012. Mr. Pearson had
8-K
GLYC
GlycoMimetics Inc
10 Jul 14
Glycomimetics Appoints Mark A. Goldberg, M.D. to Board of Directors
12:00am
Strategy of Synageva BioPharma Corp., a biopharmaceutical company, since January 2014 and was the Senior Vice President of Medical and Regulatory Affairs
8-K
EX-99.1
GLYC
GlycoMimetics Inc
31 Oct 14
Glycomimetics Reports Third Quarter 2014 Results
12:00am
about its strategy, clinical development of its therapeutic candidates, its plans for potential future product candidates and other statements containing
8-K
EX-99.2
5hgpeq69yxt4xkk
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
8-K
EX-99.1
4ex3bfrvuusi ra03
3 May 18
Glycomimetics Reports First Quarter 2018 Results
8:30am
8-K
EX-99.1
wlgjnkb1o mwic
2 Aug 23
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023
8:35am
8-K
EX-99.1
sbd4c1ruqs
3 Nov 23
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
8:35am
PRE 14A
i0i1jp0evfuvy0gebl
22 Mar 24
Preliminary proxy
5:00pm
8-K
EX-99.1
y57 v5tg01gbghfpn
1 May 20
Glycomimetics Reports Operational Highlights and Financial Results for
9:00am
8-K
EX-99.1
1ugew k6iff
3 Mar 22
GlycoMimetics Reports Highlights and Financial Results
8:45am
S-1
hnk7q swhl3ig2cfvz
4 Oct 13
IPO registration
12:00am
8-K
EX-99.1
qj35dxctq8hn71 at
28 Feb 20
Glycomimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
11:00am